Neuroleptic malignant syndrome: half a century of uncertainty suggests a Chimera

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):876-7. doi: 10.1002/pds.2008.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Causality
  • Dopamine Antagonists / adverse effects*
  • Humans
  • Malignant Hyperthermia
  • Neuroleptic Malignant Syndrome* / genetics
  • Serotonin Syndrome
  • Time Factors

Substances

  • Dopamine Antagonists